BSI is suggested for stratifying patients with prostate cancer entering treatment protocols.
Mitsui Y, Shiina H, Yamamoto Y, et al. Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer. BJU Int 2012; 110: 628-634. doi: 10.1111/j.1464-410X.2012.11355.x
Kaboteh R, Damber JE, Gjertsson P, Höglund P, Lomsky M, Ohlsson M, Edenbrandt L. Bone Scan Index: A prognostic imaging biomarker for high risk prostate cancer patients receiving primary hormonal therapy. EJNMMI Research 2013; 3: 9 doi:10.1186/2191-219X-3-9
Ulmert D, Kaboteh R, Fox JJ, et al. A novel automated platform for quantifying the extent of skeletal tumor involvement in prostate cancer patients using the Bone Scan Index. Eur Urol 2012 Jan; 78-84. doi: 10.1016/j.eururo.2012.01.037
Reza M, Bjartell A, Ohlsson M, Kaboteh R, Wollmer P, Edenbrandt L, Trägårdh E. Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy. EJNMMI Research 2014 Oct 17;4:58. doi: 10.1186/s13550-014-0058-y. eCollection 2014.